Measurable weight loss typically begins in weeks 24, with the most significant losses occurring between months 3 and 9 as the dose reaches therapeutic levels
Good communication between patients and their providers helps build trust in these treatments, especially considering factors like the mean age of participants in similar studies
YJ: Formal Analysis, Funding acquisition, Supervision, Visualization, Writing review and editing
Long-Acting GLP-1 RAs Exenatide (Bydureon) In 1987, scientists discovered that GLP-1 promotes insulin secretion, and five years later, an entero-insulin analogue, Exendin-4, which is 53% homologous to GLP-1, was isolated from the saliva of the Mexican giant lizard, later known as exenatide, which has GLP-1 receptor agonist activity and a half-life of 2.4 hours